Arkolith/Insider Trading/BIAF/Form 4

Girgenti Steven

Executive Chairman, DirectorbioAffinity Technologies, Inc. (BIAF) · full profile →Form 4 · filed Jul 6, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 1, 2023Grant(A)10K$1.83$19K889K
Apr 15, 2023Grant(A)10K$1.89$19K879K
Jan 1, 2023Grant(A)8K$2.28$19K869K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-23-023821) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML